Potential phage therapy applications: Pseudomonas lung infections in cystic fibrosis patients

Phage therapy isn’t ever going to be the cure-all envisioned by overly-enthusiastic science writers. But it doesn’t have to be. Curing some patients of some indications is a noble and worthy goal in and of itself. And maybe when we learn to use phage therapy in limited applications, we can start thinking about tackling sepsis Read More …

More flu drugs than one

The FDA today cleared a new drug for treating influenza, the first in 20 years. Xofluza (baloxovir) appears to have about the same efficacy as oseltamivir in reducing symptoms of patients with uncomplicated influenza infections. Maybe a little better: From Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents Baloxavir attacks a different target (RNA replication) Read More …